GlassScriptPhysician profile
Bertrand Tuan
NPI 1578632980
$45,461.65
in general payments reported to CMS, 2019-2025
73 companies · $2,456 in 2025
The $2,456 reported for 2025 was more than what 95% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $8,707 · 2021: $9,447 · 2022: $1,912 · 2023: $2,050 · 2024: $2,051 · 2025: $2,456.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,481 · Education: $75.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,481.46 |
| Education | $75.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $13,653.25 | 2019-2021 | |
| Rigel Pharmaceuticals, INC. | $11,445.93 | 2019-2025 | Rezlidhia, Tavalisse, Gavreto |
| Verastem, INC. | $6,600.62 | 2019-2020 | |
| Janssen Biotech, INC. | $1,679.02 | 2019-2025 | Tecvayli, Rybrevant, Darzalex |
| E.R. Squibb & Sons, L.L.C. | $615.43 | 2019-2025 | Reblozyl, Opdivo, Camzyos |
| Pfizer INC. | $594.98 | 2019-2025 | |
| Exelixis INC. | $559.65 | 2019-2024 | Cabometyx |
| Alexion Pharmaceuticals, INC. | $504.61 | 2019-2025 | Ultomiris |
| Celgene Corporation | $457.66 | 2019-2025 | Reblozyl, Opdivo, Pomalyst |
| Novartis Pharmaceuticals Corporation | $446.00 | 2019-2025 | |
| Astellas Pharma US INC | $426.69 | 2019-2025 | Padcev, Xospata, Xtandi |
| Epizyme, INC. | $407.71 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $406.53 | 2019-2025 | Keytruda, Welireg, Lenvima |
| Daiichi Sankyo INC. | $402.08 | 2020-2025 | Vanflyta, Enhertu, Datroway |
| Pharmacyclics LLC, An Abbvie Company | $394.53 | 2019-2023 | Imbruvica, Epkinly |
Show all 73 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $385.46 | 2020-2025 | Fruzaqla, Alunbrig |
| Abbvie INC. | $382.80 | 2019-2025 | Creon, Venclexta |
| Astrazeneca Pharmaceuticals LP | $345.38 | 2019-2025 | Enhertu, Imfinzi, Tagrisso |
| Octapharma USA, INC. | $344.29 | 2020-2023 | Panzyga |
| Glaxosmithkline, LLC. | $338.03 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Seagen INC. | $316.55 | 2019-2023 | Adcetris |
| Lilly USA, LLC | $309.37 | 2019-2025 | Jaypirca, Retevmo, Verzenio |
| Genzyme Corporation | $233.98 | 2019-2024 | |
| Eisai INC. | $230.62 | 2019-2025 | |
| Genentech USA, INC. | $229.53 | 2019-2025 | Polivy, Itovebi, Lunsumio |
| Gilead Sciences, INC. | $224.12 | 2021-2025 | Trodelvy |
| Amgen INC. | $220.47 | 2019-2023 | Nplate, Xgeva, Vectibix |
| Incyte Corporation | $191.90 | 2019-2024 | Jakafi, Monjuvi |
| Coherus Oncology, INC. | $180.79 | 2021-2025 | Loqtorzi |
| Adc Therapeutics America, INC. | $171.91 | 2022-2025 | |
| Servier Pharmaceuticals LLC | $159.66 | 2019-2025 | |
| Sobi, INC | $157.58 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $151.66 | 2020-2024 | Zepzelca |
| Ipsen Biopharmaceuticals, INC | $136.08 | 2022-2025 | Onivyde |
| Taiho Oncology, INC. | $133.30 | 2020-2025 | |
| Karyopharm Therapeutics INC. | $118.52 | 2020-2025 | Xpovio |
| Blueprint Medicines Corporation | $109.54 | 2020-2024 | Ayvakit |
| Aveo Pharmaceuticals, INC. | $101.88 | 2022-2025 | Fotivda |
| Puma Biotechnology, INC. | $101.36 | 2019-2024 | |
| Beigene USA, INC. | $94.21 | 2021-2025 | Tevimbra |
| Pharmaessentia USA Corporation | $85.22 | 2023-2024 | Besremi |
| Regeneron Healthcare Solutions, INC. | $82.03 | 2023-2025 | Libtayo |
| Deciphera Pharmaceuticals INC. | $80.59 | 2023-2025 | Qinlock, Romvimza |
| Pharmacosmos Therapeutics INC. | $79.65 | 2021-2024 | Cosela |
| Mirati Therapeutics, INC. | $77.42 | 2023-2024 | Krazati |
| Springworks Therapeutics, INC. | $76.08 | 2024-2025 | Ogsiveo |
| Secura Bio, INC. | $72.27 | 2022-2025 | Copiktra |
| Acrotech Biopharma INC. | $70.73 | 2021-2025 | Beleodaq |
| Syndax Pharmaceuticals, INC. | $57.48 | 2025 | Revuforj |
| Kite Pharma, INC. | $56.60 | 2020-2023 | Yescarta |
| Bayer Healthcare Pharmaceuticals INC. | $53.85 | 2024-2025 | |
| Array Biopharma INC | $51.45 | 2019-2020 | |
| Agios Pharmaceuticals, INC. | $44.24 | 2019-2025 | Pyrukynd |
| Apellis Pharmaceuticals, INC. | $42.25 | 2023-2024 | Empaveli |
| Kyowa Kirin, INC. | $41.78 | 2022-2025 | |
| Dova Pharmaceuticals | $40.11 | 2020-2021 | |
| Spectrum Pharmaceuticals INC. | $39.32 | 2019-2025 | Rolvedon |
| Clovis Oncology, INC. | $38.36 | 2019 | |
| Amag Pharmaceuticals, INC. | $37.87 | 2020-2021 | |
| Emd Serono, INC. | $37.70 | 2019-2021 | |
| Tesaro, INC. | $36.51 | 2019 | |
| Geron Corporation | $35.95 | 2025 | Rytelo |
| Stemline Therapeutics INC. | $34.66 | 2025 | Orserdu |
| Sirtex Medical INC | $30.52 | 2019 | |
| Genmab U.S., INC. | $27.10 | 2025 | Epkinly |
| Beone Medicines USA, INC. | $26.83 | 2025 | Brukinsa |
| Novocure INC. | $25.88 | 2025 | Optune Lua (Novottf-200t) |
| Cti Biopharma Corp. | $25.30 | 2023 | Vonjo |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.12 | 2021 | |
| Mylan Institutional INC. | $19.90 | 2020 | |
| Accord Healthcare, INC. | $17.15 | 2025 | |
| Myriad Genetic Laboratories, INC. | $16.34 | 2023 | Precisetumor |
| Aurobindo Pharma USA, INC. | $14.71 | 2020 |
Drugs and devices associated with these payments
Reblozyl $403Epkinly $256Imbruvica $238Enhertu $227Keytruda $220Fruzaqla $213Cabometyx $194Vanflyta $178Adcetris $145Opdivo $145Lenvima $132Jaypirca $119Vonjo $116Elrexfio $113Onivyde $111Ibrance $109Loqtorzi $108Padcev $105Welireg $100Ojjaara $89.26Xpovio $88.94Zejula $88.72Jemperli $88.72Panzyga $86.01Besremi $85.22Bosulif $83.37Libtayo $82.03Qinlock $80.59Creon $79.93Krazati $77.42Ogsiveo $76.08Scemblix $74.72Zepzelca $74.66Fotivda $73.11Tukysa $71.39Lonsurf $71.21Trodelvy $70.40Kisqali $68.60Tecvayli $65.29Alunbrig $63.36Imfinzi $63.02Datroway $62.84Rezlidhia $62.10Tavalisse $62.10Xtandi $61.98Xospata $61.65Ayvakit $60.72Retevmo $60.41Verzenio $60.41Fabhalta $58.05Nubeqa $53.85Venclexta $53.77Voranigo $52.28Copiktra $50.73Zynlonta $50.21Doptelet $49.55Tasigna $49.23Tibsovo $42.87Jakafi $42.00Rybrevant $41.61Paxlovid $40.93Ultomiris $39.53Eliquis $38.93Beleodaq $37.71Rytelo $35.95Camzyos $35.75Orserdu $34.66Udenyca $34.05Tevimbra $33.93Piqray $33.62Tagrisso $32.70Polivy $32.49Itovebi $31.63Lunsumio $31.29Xofigo $30.94Lutathera $30.82Xgeva $30.62Nplate $30.62Vectibix $30.62Yescarta $30.54Inqovi $30.51Romvimza $30.12Sarclisa $28.66Revuforj $27.37Brukinsa $26.83Darzalex $26.46Optune Lua (Novottf-200t) $25.88Vyloy $24.92Kyprolis $24.46Rolvedon $23.49Pyrukynd $23.11Enjaymo $23.07Cablivi $23.07Poteligeo $22.94Vitrakvi $22.91Stivarga $22.91Empaveli $22.09Erleada $21.70Pomalyst $21.18Monjuvi $20.92
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bertrand Tuan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.